Pay in 4 interest-free payments of $5.17 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Average Weight Loss on Semaglutide In the main clinical trial that supported semaglutide's approval for weight management (the STEP 1 trial), adults who took the 2.4 mg weekly dose lost, on average, about 15% of their body weight over 68 weeks, compared with a much smaller amount in the placebo group
Wegovy is a glucagon-like peptide-1 (GLP-1) receptor agonist licensed in the UK for obesity treatment, and whilst it affects glucose metabolism, its risk of causing hypoglycaemia varies significantly depending on whether you have diabetes and what other medications you take
For example if you weigh 130 lbs you should take between ~1200mg and 2400mg a day
It compared 11 different weight loss drugs
US$ 23.38
US$ 26.65
US$ 24.61
US$ 22.20
US$ 20.47
US$ 23.27
US$ 26.14
